Browse drugs

…(median midazolam dose 5mg [3-7] vs 4.5mg [3-6], p=0.04, median fentanyl 100 mcg [50-100] vs 75 [50-100], p <0.01). No statistically sig…

…ral KPIs improved after the Introduction of automated feedback. Buscopan use doubled (median 5.01% → 10.20%, p<0.001), and small but sig…

… adults undergoing elective VATS received an infusion of either 0.2% ropivacaine or saline via a SAPB catheter, in addition to standardized mult…

…he patient achieved clinical remission following treatment with intravenous cyclophosphamide and corticosteroids.…

…ce was among melanoma patients receiving combination therapy of ipilimumab and nivolumab, 19% developed ChILI.Liver injury was not attribu…

…th axial T2-weighted imaging at L3. Abdominal fat segmentation (Entrolytics, Motilent) derived visceral (VAT), subcutaneous (SAT), and tota…

…egistry follow-up data of the BEST3 cohort demonstrate that the CS-TFF3 screening approach is not associated with missed OAC. Even when…

…us hepatitis; fibrosis staging available in a subset.Treatment: Ursodeoxycholic, corticosteroids, or combination; treatment modality was not si…

…ed long-term anticoagulation tailored to thrombotic risk, using vitamin K antagonists or direct oral anticoagulants, with targeted etiological treatm…

… final follow-up. Procedural technical variables were recorded. Proton pump inhibitor (PPI) use and patient-reported satisfaction were assessed.Resul…

… median 5 per patient; range 1–16). Six patients (21%) received intralesional triamcinolone. The interval between dilatations ranged from less than 2 weeks…

…e high sedation doses - mean fentanyl 104.5 ± 43.6 mcg and mean midazolam 5.57 ± 1.8 mg - these patients failed to achieve adequate sedat…